Key points are not available for this paper at this time.
This meta-analysis reveals that the NLR represents a promising biomarker that can serve as a prognostic indicator in patients with FG. Future studies should address the establishment of proper disease-specific cutoff values to aid in clinical decision-making.
Seretis et al. (Thu,) studied this question.